Traitements3programmes
Essais1liés
Publications6liées
SourceDBlocale

Traitements

3
MoléculeIndication / populationPhaseObjectifPaysRésultat
Lead insertionThe objective of this study is to assess the safety and performance of the SPIKE FLOW endocardial lead. Primary objectives are to assess: * safety in terms of freedom from Serious Adverse Events(SADEs); * performance in terms of Mean Pacing Capture Threshold. Secondary objectives are to assess: * safety in terms of freedom from Adverse Events (ADEs); * performance in terms of Mean Pacing Impedance; * performance in terms of Sensed R-wave Amplitude. The study is a prospective, non-randomized, single-arm, multi-center investigation in 131 adult subjects with 3 investigational sites in Italy. The study is expected to take approximately 1 year to enroll. Enrolled subjects will have visit timepoints at: baseline, lead insertion, lead removal, discharge and 30 days post lead removal. Maladie coronarienne Non applicable À vérifier Italy À vérifier
lead removalThe objective of this study is to assess the safety and performance of the SPIKE FLOW endocardial lead. Primary objectives are to assess: * safety in terms of freedom from Serious Adverse Events(SADEs); * performance in terms of Mean Pacing Capture Threshold. Secondary objectives are to assess: * safety in terms of freedom from Adverse Events (ADEs); * performance in terms of Mean Pacing Impedance; * performance in terms of Sensed R-wave Amplitude. The study is a prospective, non-randomized, single-arm, multi-center investigation in 131 adult subjects with 3 investigational sites in Italy. The study is expected to take approximately 1 year to enroll. Enrolled subjects will have visit timepoints at: baseline, lead insertion, lead removal, discharge and 30 days post lead removal. Maladie coronarienne Non applicable À vérifier Italy À vérifier
Lead insertionThe objective of this study is to assess the safety and performance of the SPIKE FLOW endocardial lead. Primary objectives are to assess: * safety in terms of freedom from Serious Adverse Events(SADEs); * performance in terms of Mean Pacing Capture Threshold. Secondary objectives are to assess: * safety in terms of freedom from Adverse Events (ADEs); * performance in terms of Mean Pacing Impedance; * performance in terms of Sensed R-wave Amplitude. The study is a prospective, non-randomized, single-arm, multi-center investigation in 131 adult subjects with 3 investigational sites in Italy. The study is expected to take approximately 1 year to enroll. Enrolled subjects will have visit timepoints at: baseline, lead insertion, lead removal, discharge and 30 days post lead removal. Maladie coronarienne Non applicable À vérifier Italy À vérifier

Essais cliniques

1
MoléculeIndication / populationPhaseNCTTitreStatut
Lead insertion Maladie coronarienne Non applicable NCT07820072 SPIKE FLOW Endocardial Lead Safety and Performance Study RECRUITING

Publications

6
MoléculeIndication / populationTitreJournalDate
Lead insertion Comparative analysis of ultrasound-guided versus fluoroscopy-guided venous puncture techniques for pacemaker implantation. Heart and vessels
Lead insertion 'Asleep' deep brain stimulation targeting ventral intermediate thalamus in essential tremor: systematic review. British journal of neurosurgery
Lead insertion The flexibility of delayed fluoroscopic left ventricular angiography in periprocedural real-time visualization of the lead tip in left bundle branch pacing. Heart rhythm O2
lead removal Safety and Outcomes of Transvenous Lead Extraction of Advisory ePTFE-Coated Implantable Cardioverter-Defibrillator Leads: A Multicenter Experience With RELIANCE G. JACC. Clinical electrophysiology
lead removal Confluence of nanotechnology and phytoremediation for lead detoxification using . International journal of phytoremediation
lead removal Retraction notice to "Artificial neural networks modeling for lead removal from aqueous solutions using iron oxide nanocomposites from bio-waste mass" [Environ. Res. 199 (2021) 111370]. Environmental research